This site is intended for health professionals only

Covid-19 Primary Care Resources

Other conditions

QCovid Risk Calculator Diabetes Mental Health Socially Vulnerable Groups Staff Support Testing, Trials and Research

Additional people are now being added to the Shielded Patient List using the QCovid risk calculator

Guidance on steroid prescribing Prescribing

There is still concern that steroids can increase the risk from Covid-19

Long term condition reviews Diabetes Respiratory Conditions

Tools to support remote assessments – new content added

Advice for smokers and vapers Testing, Trials and Research

Guidance and emerging evidence on risks of smoking, vaping and illness severity of Covid-19

Neurological conditions Isolation and Social Distancing Prescribing

Guidance on Covid-19 risk to people with neurological conditions, and specific therapies in MS

Rheumatology patients Isolation and Social Distancing Prescribing

Routine monitoring of DMARDs, and assessment/ treatment of suspected Covid-19 in patients on immunosuppressants

Chronic Kidney Disease Post-viral recovery Triage and Treatment

A summary of the NICE Covid-19 rapid guideline on CKD

ACE Inhibitors and ARBs Prescribing

Summary of relevant guidance and emerging evidence for primary care

Splenectomy Categorising Risk Groups Isolation and Social Distancing

Who should shield, and precautions for all patients with splenectomy during the pandemic

Recommendations for home blood pressure monitoring

Advising patients on how to monitor BP reliably

Anticoagulation Prescribing

Prescribing during the pandemic

Brugada syndrome or Long QT syndrome

The care pathway is dependent on whether the patient has an ICD

Heart Failure Isolation and Social Distancing

British Society for HF advice on shielding, and who to prioritise for review

How to convert to oral B12 for patients established on IM hydroxocobalamin Prescribing

British Society for Haematology provide guidance on vitamin B12 replacement during the COVID-19 pandemic


There is no evidence for a higher Covid-19 infection rate or different disease course in people living with HIV